Safety of Nonsteroidal Anti‐inflammatory Drugs in Major Gastrointestinal Surgery: A Prospective, Multicenter Cohort Study
Adult
Male
Anti-Inflammatory Agents, Non-Steroidal
Middle Aged
Anastomotic leak rate
3. Good health
03 medical and health sciences
Logistic Models
Postoperative Complications
0302 clinical medicine
616
Major complication rate
Anastomotic leak
Humans
Female
Prospective Studies
Ketorolac
Propensity match
Digestive System Surgical Procedures
Aged
DOI:
10.1007/s00268-016-3727-3
Publication Date:
2016-10-20T12:10:33Z
AUTHORS (1155)
ABSTRACT
AbstractBackgroundSignificant safety concerns remain surrounding the use of nonsteroidal anti‐inflammatory drugs (NSAIDs) following gastrointestinal surgery, leading to wide variation in their use. This study aimed to determine the safety profile of NSAIDs after major gastrointestinal surgery.MethodsConsecutive patients undergoing elective or emergency abdominal surgery with a minimum one‐night stay during a 3‐month study period were eligible for inclusion. The administration of any NSAID within 3 days following surgery was the main independent variable. The primary outcome measure was the 30‐day postoperative major complication rate, as defined by the Clavien–Dindo classification (Clavien–Dindo III–V). Propensity matching with multivariable logistic regression was used to produce odds ratios (OR) and 95 % confidence intervals.ResultsFrom 9264 patients, 23.9 % (n = 2212) received postoperative NSAIDs. The overall major complication rate was 11.5 % (n = 1067). Following propensity matching and adjustment, use of NSAIDs were not significantly associated with any increase in major complications (OR 0.90, 0.60–1.34, p = 0.560).ConclusionsEarly use of postoperative NSAIDs was not associated with an increase in major complications following gastrointestinal surgery.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (26)
CITATIONS (19)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....